Hyperhomocysteinaemia and chronic venous ulcers

International Wound Journal

Volumn 12, Issue 1, 2015, Pages 22-26

  de Franciscis, Stefano ^a   De Sarro, Giovambattista ^a   Longo, Paola ^a   Buffone, Gianluca ^a   Molinari, Vincenzo ^a   Stillitano, Domenico M ^a   Gallelli, Luca ^a   Serra, Raffaele ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Chronic venous disease; Chronic venous ulceration; Hyperhomocysteinaemia; Thrombophilia; Venous leg ulcer

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CHRONIC WOUND; COMPRESSION THERAPY; CONTROLLED STUDY; DISEASE ASSESSMENT; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; LEG ULCER; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; WOUND HEALING;

EID: 84873966569     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/iwj.12042     Document Type: Article

References (23)

1. Serra R, Buffone G, de Franciscis A, Mastrangelo D, Vitagliano T, Greco M, de Franciscis S. Skin grafting followed by low-molecular-weight heparin long-term therapy in chronic venous leg ulcers. Ann Vasc Surg 2012;26:190-7.
2. Reichenberg J, Davis M. Venous ulcers. Semin Cutan Med Surg 2005;24:216-26.
3. Serra R, Buffone G, de Franciscis A, Mastrangelo D, Molinari V, Montemurro R, de Franciscis S. A genetic study of chronic venous insufficiency. Ann Vasc Surg 2012;26:636-42.
4. Serra R, Buffone G, Costanzo G, Montemurro R, Perri P, Damiano R, de Franciscis S. Varicocele in younger as risk factor for inguinal hernia and for chronic venous disease in older: preliminary results of a prospective cohort study. Ann Vasc Surg 2012 in press. DOI: 10.1016/j.avsg.2012.03.016.
5. Serra R, Buffone G, Falcone D, Molinari V, Scaramuzzino M, Gallelli L, de Franciscis S. Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase associated lipocalin. Wound Repair Regen 2012 in press. DOI: 10.1111/wrr12035.
6. Darvall KA, Sam RC, Adam DJ, Silverman SH, Fegan CD, Bradbury AW. Higher prevalence of thrombophilia in patients with varicose veins and venous ulcers than controls. J Vasc Surg 2009;49:1235-41.
7. Sam RC, Burns PJ, Hobbs SD, Marshall T, Wilmink AB, Silverman SH, Bradbury AW. The prevalence of hyperhomocysteinemia, methylene tetrahydrofolate reductase C677T mutation, and vitamin B12 and folate deficiency in patients with chronic venous insufficiency. J Vasc Surg 2003;38:904-8.
8. De Bree A, Verschuren WM, Kromhout D, Kluijtmans LA, Blom HJ. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev 2002;54:599-618.
9. Boysen G, Brander T, Christensen H, Gideon R, Truelsen T. Homocysteine and risk of recurrent stroke. Stroke 2003;34:1258-61.
10. Vollset SE, Refsum H, Tverdal A, Nygård O, Nordrehaug JE, Tell GS, Ueland PM. Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordalans Homocysteine study. Am J Clin Nutr 2001;74:130-6.
11. Siniscalchi A, Mancuso F, Gallelli L, Ferreri Ibbadu G, Biagio Mercuri N, De Sarro G. Increase in plasma homocysteine levels induced by drug treatments in neurologic patients. Pharmacol Res 2005;52:367-75.
12. Siniscalchi A, Gallelli L, Mercuri NB, Ibbadu GF, De Sarro G. Role of lifestyle factors on plasma homocysteine levels in Parkinson's disease patients treated with levodopa. Nutr Neurosci 2006;9:11-6.
13. Siniscalchi A, De Sarro G, Loizzo S, Gallelli L. High plasma homocysteine and low serum folate levels induced by antiepileptic drugs in Down syndrome. JoDD 2012;18:70-6.
14. Eklöf B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, Meissner MH, Moneta GL, Myers K, Padberg FT, Perrin M, Ruckley CV, Smith PC, Wakefield TW. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004;40:1248-52.
15. De Luca G, Suryapranata H, Gregorio G, Lange H, Chiariello M. Homocysteine and its effects on in-stent restenosis. Circulation 2005;112:e307-11.
16. Melhem A, Desai A, Hofmann MA. Acute myocardial infarction and pulmonary embolism in a young man with pernicious anemia-induced severe hyperhomocysteinemia. Thromb J 2009;7:5.
17. Lawrence de Koning AB, Werstuck GH, Zhou J, Austin RC. Hyperhomocysteinemia and its role in the development of atherosclerosis. Clin Biochem 2003;36:431-41.
18. Raposo B, Rodríguez C, Martínez-González J, Badimon L. High levels of homocysteine inhibit lysyl oxidase (LOX) and downregulate LOX expression in vascular endothelial cells. Atherosclerosis 2004;177:1-8.
19. Schwartzfarb EM, Romanelli P. Hyperhomocysteinemia and lower extremity wounds. Int J Low Extrem Wounds 2008;7:126-36.
20. Bradbury AW, MacKenzie RK, Burns P, Fegan C. Thrombophilia and chronic venous ulceration. Eur J Vasc Endovasc Surg 2002;24:97-104.
21. Jacovina AT, Deora AB, Ling Q, Broekman MJ, Almeida D, Greenberg CB, Marcus AJ, Smith JD, Hajjar KA. Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. J Clin Invest 2009;119:3384-94.
22. Maron BA, Loscalzo J. The treatment of hyperhomocysteinemia. Annu Rev Med 2009;60:39-54.
23. Lee M, Hong KS, Chang SC, Saver JL. Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis. Stroke 2010;41:1205-12.